5 Fluorodeoxyuridine en es it fr

5 Fluorodeoxyuridine Brand names, 5 Fluorodeoxyuridine Analogs

5 Fluorodeoxyuridine Brand Names Mixture

  • No information avaliable

5 Fluorodeoxyuridine Chemical_Formula

C9H11FN2O5

5 Fluorodeoxyuridine RX_link

http://www.rxlist.com/cgi/generic2/floxuridine.htm

5 Fluorodeoxyuridine fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/labels.cfm?GN=floxuridine%20(intraarterial)

5 Fluorodeoxyuridine msds (material safety sheet)

5_Fluorodeoxyuridine MSDS

5 Fluorodeoxyuridine Synthesis Reference

No information avaliable

5 Fluorodeoxyuridine Molecular Weight

246.193 g/mol

5 Fluorodeoxyuridine Melting Point

150.5 oC

5 Fluorodeoxyuridine H2O Solubility

1.19E+004 mg/L

5 Fluorodeoxyuridine State

Solid

5 Fluorodeoxyuridine LogP

-1.249

5 Fluorodeoxyuridine Dosage Forms

Powder for solution (500mg vial)

5 Fluorodeoxyuridine Indication

For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means.

5 Fluorodeoxyuridine Pharmacology

Floxuridine is a pyrimidine analog that acts as an inhibitor of the S-phase of cell division. This selectively kills rapidly dividing cells. Floxuridine is an anti-metabolite. Anti-metabolites masquerade as pyramidine-like molecules which prevents normal pyrimidines from being incorporated into DNA during the S phase of the cell cycle. Flurouracil (the end-product of catabolism of floxuridine) blacks an enzyme which converts cytosine nucleosides into the deoxy derivative. In addition, DNA synthesis is further inhibited because fluoruracil blocks the incorporation of the thymdine nucleotide into the DNA strand.

5 Fluorodeoxyuridine Absorption

No information avaliable

5 Fluorodeoxyuridine side effects and Toxicity

Oral, rat LD50: 215 mg/kg. Signs of overdose include nausea, vomiting, diarrhea, gastrointestinal ulceration and bleeding, and bone marrow depression (including thrombocytopenia, leukopenia and agranulocytosis).

5 Fluorodeoxyuridine Patient Information

5 Fluorodeoxyuridine Organisms Affected

Humans and other mammals